CONTENTS

Issue 85 | August 2019

In association with

drug resistance 

Understanding and treating the growing threat of drug-resistant tuberculosis

HIV: timeline

A look back at breakthrough moments in the hunt to prevent and treat HIV

a costly error

Accusations of price fixing have added fuel to the fire of Teva's dramatic downfall

stem cells

Exploring the dangers of clinics marketing unlicensed stem cell treatments

hear ye! Hear ye!

Research suggests that cancer cells can communicate further that we thought

copd: a revolution?

How might Verona’s ensifentrine revolutionise treatment for COPD?

Q&A | Industry

How can Big Pharma solve the problem of balancing patents and patients?

‘Pay As You Go’

Introducing a ‘pay as you go’ database of AI programmes for drug discovery in the UK

02/24/2024 05:23:07
  • Home | Taming the pharma beast
  • In this issue
  • Emirates SkyCargo
  • Contents
  • TSS Company Insight
  • News
  • Daiichi Jitsugyo
  • ICCI Company Insight
  • ICCI
  • The pharma industry briefing
  • Novo Nordisk
  • Swiss WorldCargo
  • Understanding drug-resistant TB
  • CBDepot Company Insight
  • CBDepot
  • Through time: the breakthroughs that changed the course of HIV treatment
  • Senn Chemicals
  • Qatar Airways
  • Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woes
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • The dangers of unlicensed stem cell clinics
  • Komtur Pharmaceuticals
  • How do cancer cells communicate and can it help us catch them?
  • Verona’s ensifentrine: a potentially revolutionary treatment for COPD
  • Taming the pharma monster with Hedley Rees
  • Capsugel Company Insight
  • Altheria Solutions
  • ‘Pay As You Go’ AI for drug discovery
  • AtoZ-CRO GmbH
  • PharmaHemp
  • Event: CPhl Korea
  • Events
  • Centaur Clinical | Company Insight
  • Centaur Clinical
  • Next issue
  • Hapa Company Insight
  • Pfanstiehl
07/29/2019 00:00:00